微创直视冠状动脉旁路移植术二十年结局:莱比锡经验
该研究回顾1996至2018年共2667例接受微创直视冠状动脉旁路移植术(MIDCAB)的患者,按手术年份分为三组,比较组间特征与早期结局,并分析长期生存及晚期死亡预测因素。结果显示总体住院死亡率为0.9%,10年、15年和20年生存率分别为77.7±0.9%、66.1±1.2%和55.6±1.6%,尽管患者 demographic 特征恶化,住院死亡率在22年间保持稳定。
要点
- MIDCAB可安全施行,早期和长期结局良好。
- 22年间住院死亡率保持稳定,尽管患者风险特征恶化。
- 总体10年、15年、20年生存率分别为77.7%、66.1%、55.6%。
核心结论
- MIDCAB可安全施行,早期和长期结局良好。
- 尽管患者 demographic 特征恶化,住院死亡率在22年研究期间保持稳定。
研究设计与样本
- 回顾性队列研究,纳入1996至2018年接受MIDCAB的2667例患者。
- 按手术年份分为三组:A组1996-2003年(n=1333)、B组2004-2010年(n=627)、C组2011-2018年(n=707)。
- 比较组间特征和早期术后结局,分析全部患者长期生存,并使用Cox比例风险模型识别晚期死亡预测因素。
主要发现
- 平均年龄64.5±10.9岁,女性691例(25.9%)。
- C组患者(log EuroSCORE I=4.9±6.9)较A组(3.1±4.5)和B组(3.5±4.7)年龄更大,心脏危险因素和合并症更多。
- 全部患者总体10年、15年和20年生存估计分别为77.7±0.9%、66.1±1.2%和55.6±1.6%。
临床怎么用
- 对于孤立性复杂左前降支冠状动脉病变患者,MIDCAB可作为一种安全的手术选择。
- 尽管患者风险特征随时间恶化,MIDCAB的住院死亡率保持稳定,支持其可常规用于特定中心。
局限性
- 原文未明确报告研究局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Minimally invasive direct coronary artery bypass (MIDCAB) surgery involving left anterior descending coronary artery grafting with the left internal thoracic artery through a left anterior small thoracotomy is being routinely performed in some specified centers for patients with isolated complex left anterior descending coronary artery disease, but very few reports regarding long-term outcomes exist in literature. Our study was aimed at assessing and analyzing the early and long-term outcomes of a large cohort of patients who underwent MIDCAB procedures and identifying the effects of changing trends in patient characteristics on early mortality. METHODS: A total of 2667 patients, who underwent MIDCAB procedures between 1996 and 2018, were divided into 3 groups on the basis of the year of surgery: group A, 1996-2003 (n = 1333); group B, 2004-2010 (n = 627) and group C, 2011-2018 (n = 707). Groupwise characteristics and early postoperative outcomes were compared. Long-term survival for all patients was analyzed and predictors for late mortality were identified using Cox proportional hazards methods. RESULTS: The mean age was 64.5 ± 10.9 years and 691 (25.9%) patients were female. Group C patients (log EuroSCORE I = 4.9 ± 6.9) were older with more cardiac risk factors and comorbidities than groups A (log EuroSCORE I = 3.1 ± 4.5) and B (log EuroSCORE I = 3.5 ± 4.7). Overall and groupwise in-hospital mortality was 0.9%, 1.0%, 0.6%, and 1.0% (P = .7), respectively. Overall 10-, 15-, and 20-year survival estimates for all patients were 77.7 ± 0.9%, 66.1 ± 1.2%, and 55.6 ± 1.6%, respectively. CONCLUSIONS: MIDCAB can be safely performed with very good early and long-term outcomes. In-hospital mortality remained constant over the 22-year period of the study despite worsening demographic profile of patients.
引用
- Davierwala PM, Verevkin A, Bergien L, et al. Twenty-year outcomes of minimally invasive direct coronary artery bypass surgery: The Leipzig experience. J Thorac Cardiovasc Surg. 2021. PMID: 33757682. doi:10.1016/j.jtcvs.2020.12.149
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。